- Bristol Myers’ pivotal year; Should AI be swinging bigger?; and moreWelcome back to Endpoints Weekly! The last week of April brought a downpour of news as several pharma companies reported their first-quarter earnings. Max Gelman took a close look at a make-or-brea…Endpoints · 2mo ago↗ source
- Moderna in talks with FDA over Phase 4 Covid vaccine dataModerna said it's working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after FDA leaders narrowed the label for the produ…Endpoints · 2mo ago↗ source
- FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming dataThe FDA on Friday approved Pfizer and Arvinas' drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will take it. The drug will be ...